Hadassah

Hadassah University Medical Center Clinical Trial Reveals Success of New Treatment Combination for Post-Traumatic Stress Disorder

Monday, Sep 12 2011

Results of a clinical trial at the Hadassah University Medical Center indicate that Deep Transcranial Magnetic Stimulation (TMS) can be an effective treatment for Post-Traumatic Stress Disorder (PTSD) when combined with exposure to trauma memory cues.

TMS is a noninvasive procedure that uses magnetic fields to stimulate nerve cells in the brain. "This study," relates Principal Investigator Dr. Moshe Isseries of Hadassah's Department of Psychiatry, "was the first of its kind designed to test the effectiveness of TMS on people with severe or resistant PTSD." Only a few studies, he says, "have been conducted using magnetic stimulation and none using the combination of magnetic stimulation and exposure to trauma memory."

The trial involved an innovative device, developed by the Israeli company, Brainsway Ltd, which stimulates extensive areas deeper in the cortex. The 26 patients in the trial were divided into three groups: One group was treated using the Deep TMS device together with a brief exposure to trauma cues (reminders of a traumatic event conveyed to the patient through earphones); a second group received Deep TMS treatment with no trauma cues; and a third group received sham stimulation with exposure to trauma cues. All the patients in the study participated in at least 8 sessions, the minimum required for treatment.
Only the group that received active Deep TMS with exposure to cues showed a statistically significant improvement. "There was a marked decrease in nightmares and flashbacks and improvement in sleeping, mood, and functioning," Dr. Isseries reports. Follow-up questionnaires yielded similar findings. The improvement remained constant.

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Wednesday, Aug 16 2017

Gazan Boy Walks for First Time at Hadassah

Unable to stand on his feet, suffering from severe respiratory distress, a four-year-old boy from Gaza gained the ability to walk once Hadassah Hospital surgeons identified and removed a large tumor lodged in his chest.

READ MORE ›
alt_text

Wednesday, Aug 16 2017

Hadassah Hosts Health Innovation Conference

Over one hundred doctors, researchers, and entrepreneurs gathered at Hadassah Hospital Ein Kerem this summer to discuss how to advance the quality of patient care with computational power.

READ MORE ›
alt_text

Monday, Aug 14 2017

Hadassah Hosts First Human Trial with Drug to Fight Nasty Bacterial Infection

Immuron, an Australian biopharmaceutical company, has received approval from the Hadassah Medical Organization’s ethics committee and Israel’s Ministry of Health to begin its first clinical trial with a new drug to fight a bacterial infection called Clostridium Difficile (CDI).

READ MORE ›
alt_text

Thursday, Aug 3 2017

Mystery of Devastating Pediatric Disease Solved by Hadassah Team

A genetic mutation causing a rare and devastating pediatric neurological disease that has puzzled medical centers around the world has been identified at the Hadassah Medical Organization by Prof. Orly Elpeleg, head of Hadassah's Department of Genetics and Metabolic Diseases.

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More